ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

Karkin, Hatfield Vow to Amend Health Reform To Include Trust Fund For Medical Research

June 4, 1993

ACS Did Not Sign Bumpers Letter

May 1, 1992

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007